Medical Information in Asia-Pacific

Access 25 years of world-class medical information services in Asia-Pacific

Why Choose ProPharma?

We’re proud to offer over 25 years of expertise in delivering Medical Information services. Our team of experts can ensure the safe and effective use of your healthcare products, while maintaining compliance with local regulatory environments. Regardless of your location, you’ll receive the same, consistent high-level of service.

Woman in lab coat wearing headset stethoscope typing on laptop

Consistent, High-Quality Services To Meet Your Needs

If you’re a global company, looking to strengthen your presence in the Asia-Pacific and Japanese market, or a company headquartered in the region, our Medical Information services are customizable, so can be tailored to your business’ size and needs.

customer-service-professional-wearing-headset-asking-coworker-a-question-ss-2149603273

Contact Center Support

With our scalable contact centers across the region, with optional 24-7 availability, we offer multilingual support from native-speaking medical professionals. This enables us to respond to patients, healthcare professionals, and other inquirers in a swift manner that is consistent with both country regulations and license and the inquirer's local cultural and communication etiquette. In Asia-Pacific, our experts can provide support in Japanese, Cantonese, Korean, Thai, Mandarin, Vietnamese, Filipino, Hindi, Indonesian, and English.
 
Healthcare worker showing patient something

Patient Support Services

We offer solutions to support patients, caregivers, and healthcare professionals to initiate and sustain therapies, helping them to overcome barriers and achieve better health outcomes. Our services include disease state education, for better understanding and informed decision-making, drug administration assistance, adherence outreach, patient helplines, caregiver support, concierge services, and connections to advocacy programs. 

 

Healthcare professional writing

Medical Writing

Our team of expert writers, editors, and quality reviewers understand the importance of providing clear, concise text for your clinical, scientific, and regulatory needs, in addition to ensuring your content remains up-to-date and compliant. With bilingual, native-speaking medical professionals, we also ensure that content is consistent with local requirements, culture, and communication styles. We can create or translate documents in more than 35 languages globally, including Japanese, Cantonese, Korean, Thai, Mandarin, Vietnamese, Filipino, Hindi, Indonesian, and English.

Expertise Across Asia-Pacific

With expert teams located across Asia-Pacific, we ensure local needs and requirements are not only covered, but also respected.

India

We have a fully integrated Medical Information (MI) Contact Center based in Hyderabad, India that is strategically positioned to offer our clients the ability to have the MI service options they’ve come to know from ProPharma, however at competitive low costs, while maintaining a high level of quality and customer excellence. India is a direct extension of the teams they support in US, EU, and APAC regions and can support local service hours.

Philippines

We have a fully integrated Medical Information (MI) Contact Center based in Manila, Philippines that is strategically positioned to offer our clients competitively priced solutions, while providing piece of mind that their services are supported by experienced medical professionals with excellent English language skill, and years of relevant experience. Philippines is a direct extension of the teams they support in regions such as APAC, US, EU, supporting the local service hours.

Japan

We have a fully integrated Medical Information (MI) Contact Center based in Tokyo, Japan. Our experts, who are qualified Japanese healthcare professionals, work with local GVP knowledge, so they can identify and respond to adverse events in accordance to the guidelines. The team can also provide support using communication channels that work for you, including SMS, SNS, email, chat, and phone calls.

Korea

As our expert team are native Korean speakers, they understand the importance of cultural communication etiquette. This includes the hierarchical structure in Korean businesses, such as the significance of respecting seniority, and they also keep on top of local social issues that may arise and cause disruptions. Our teams also have thorough knowledge of the Personal Information Protection Act (PIPA), ensuring they adhere to the requirements of the act.

Asia-Pacific Medical Information Experts

  • Leanne Shaw Bio Photo

    Leanne Shaw

    Vice President, Medical Information

    View Bio

  • Matthew Wong Bio Photo

    Matthew Wong

    Director, Medical Information, JAPAC

    View Bio

  • Yuka Terashima Bio Photo

    Yuka Terashima

    Director, Medical Information

    View Bio

Leanne brings 15 years of Medical Information Contact Center Management and Operations experience across Europe and Asia Pacific. Leanne begun her career in this space as a UK Medical Information Specialist and has continually advanced into roles of increasing responsibility including client management, operations management, and project leadership. Leanne is currently the Senior Director of Medical Information Services for JAPAC at ProPharma. Leanne’s key focus on service evolution and customer excellence helps deliver JAPAC services to the highest standard of success.

Matthew serves as the Director of Medical Information for the Asia-Pacific (APAC) region, bringing over 12 years of expertise in Medical Information and decade of experience in Contact Center Management. He holds a Bachelor of Pharmacy (Honours) and a Master’s degree in Public Health, specializing in Health Economics.

In his current role, Matthew leads the strategic and operational success of the APAC Medical Information function, ensuring the consistent delivery of high-quality services to clients across the region. He is deeply committed to advancing best-in-class Medical Information solutions and driving innovation to improve patient outcomes.

I have worked with several pharmaceutical companies, for those companies, with vast varieties of experiences, R&D project manager, Medical Writer, Business Development and Strategy, Oncology Marketing, Medical Affairs for Oncology and Medical Information.

News & Insights

From Feasibility to First Patient In: Streamlining Study Start‑Up with Confidence

July 27, 2026

From Feasibility to First Patient In: Streamlining Study Start‑Up with Confidenc...

Discover how ProPharma streamlines clinical trial study start-up, ensuring predictable activation and reducing risks from feasibility to first patient in.cl

QMSR Explained: Key Changes from FDA QSR to the New Quality Management System Regulation

July 23, 2026

QMSR Explained: Key Changes from FDA QSR to the New Quality Management System Re...

The FDA's transition to the QMSR simplifies compliance, emphasizing risk management and aligning with global standards for medical devices compared to QMR.

Building Relationships with Sites: The Hidden Driver of Faster Start-Ups

July 20, 2026

Building Relationships with Sites: The Hidden Driver of Faster Start-Ups

Discover effective strategies for building relationships with clinical trial sites to streamline the study start-up process and enhance activation timelines.

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

May 27, 2026

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation - ProPharma

July 23, 2026

Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation

As artificial intelligence becomes increasingly embedded across life sciences, organizations face a growing challenge: ensuring quality and compliance frameworks evolve alongside rapidly advancing...

Case Study Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A Regulatory and Pharmacovigilance-Led Solution - ProPharma

July 15, 2026

Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A...

Product shortages involving essential medicines can create significant clinical and regulatory challenges, particularly when vulnerable patient populations depend on uninterrupted access to...

Case Study Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sensitive Research - ProPharma

June 17, 2026

Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sen...

Conducting clinical research for rare pediatric populations presents unique operational challenges, particularly when eligible patients may be born anywhere in the world and require immediate...

From Feasibility to First Patient In: How to Streamline Study Start-Up  

September 30, 2026

From Feasibility to First Patient In: How to Streamline Study Start-Up  

Clinical trial delays often begin long before study conduct, with critical decisions made during feasibility and study start-up shaping the success of the entire trial. Join this webinar to discover...

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

June 4, 2026

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Artificial intelligence (AI) is a hot topic in Medical Information (MI), yet real-world evidence of its impact in regulated, human-led MI environments remains limited. Hear practical, evidence-based...

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

News & Insights

From Feasibility to First Patient In: Streamlining Study Start‑Up with Confidence

July 27, 2026

From Feasibility to First Patient In: Streamlining Study Start‑Up with Confidenc...

Discover how ProPharma streamlines clinical trial study start-up, ensuring predictable activation and reducing risks from feasibility to first patient in.cl

QMSR Explained: Key Changes from FDA QSR to the New Quality Management System Regulation

July 23, 2026

QMSR Explained: Key Changes from FDA QSR to the New Quality Management System Re...

The FDA's transition to the QMSR simplifies compliance, emphasizing risk management and aligning with global standards for medical devices compared to QMR.

Building Relationships with Sites: The Hidden Driver of Faster Start-Ups

July 20, 2026

Building Relationships with Sites: The Hidden Driver of Faster Start-Ups

Discover effective strategies for building relationships with clinical trial sites to streamline the study start-up process and enhance activation timelines.

Previous Post Arrow Next Post Arrow
ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

May 27, 2026

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation - ProPharma

July 23, 2026

Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation

As artificial intelligence becomes increasingly embedded across life sciences, organizations face a growing challenge: ensuring quality and compliance frameworks evolve alongside rapidly advancing...

Case Study Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A Regulatory and Pharmacovigilance-Led Solution - ProPharma

July 15, 2026

Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A...

Product shortages involving essential medicines can create significant clinical and regulatory challenges, particularly when vulnerable patient populations depend on uninterrupted access to...

Case Study Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sensitive Research - ProPharma

June 17, 2026

Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sen...

Conducting clinical research for rare pediatric populations presents unique operational challenges, particularly when eligible patients may be born anywhere in the world and require immediate...

Previous Resource Arrow Next Resource Arrow
From Feasibility to First Patient In: How to Streamline Study Start-Up  

September 30, 2026

From Feasibility to First Patient In: How to Streamline Study Start-Up  

Clinical trial delays often begin long before study conduct, with critical decisions made during feasibility and study start-up shaping the success of the entire trial. Join this webinar to discover...

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

June 4, 2026

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Artificial intelligence (AI) is a hot topic in Medical Information (MI), yet real-world evidence of its impact in regulated, human-led MI environments remains limited. Hear practical, evidence-based...

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Previous Webinar Arrow Next Webinar Arrow